LY-3200882
N/A
Report date: 2024/11/20 20:00:31
NME
Base Information
Drug NameLY-3200882
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And Company
Inactive CompaniesThe Netherlands Cancer Institute
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A